William Plovanic
Stock Analyst at Canaccord Genuity
(3.80)
# 714
Out of 5,081 analysts
161
Total ratings
51.72%
Success rate
8.07%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $428 → $432 | $307.56 | +40.46% | 7 | Nov 24, 2025 | |
| HTFL HeartFlow | Maintains: Buy | $39 → $40 | $28.00 | +42.86% | 3 | Nov 13, 2025 | |
| AORT Artivion | Maintains: Buy | $50 → $51 | $45.48 | +12.14% | 4 | Nov 7, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $9 → $11 | $9.26 | +18.79% | 9 | Nov 6, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $81 → $84 | $83.98 | +0.02% | 28 | Nov 3, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $193 → $212 | $183.27 | +15.68% | 13 | Oct 31, 2025 | |
| DXCM DexCom | Maintains: Buy | $106 → $99 | $64.85 | +52.66% | 9 | Oct 31, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $142 → $147 | $140.10 | +4.93% | 8 | Oct 30, 2025 | |
| ATRC AtriCure | Maintains: Buy | $53 → $64 | $36.27 | +76.45% | 12 | Oct 30, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $132 | $98.57 | +33.91% | 12 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $13.49 | +33.43% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 | $19.93 | +20.42% | 6 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $1.34 | +422.39% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $87.75 | +2.56% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $93.10 | +8.49% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 | $6.43 | +71.07% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $18.00 | +83.33% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.57 | +98.15% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $285.71 | -0.60% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $21.23 | +17.76% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.89 | +534.92% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $84.26 | -16.92% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $26.37 | +82.03% | 5 | Aug 3, 2023 |
Insulet
Nov 24, 2025
Maintains: Buy
Price Target: $428 → $432
Current: $307.56
Upside: +40.46%
HeartFlow
Nov 13, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $28.00
Upside: +42.86%
Artivion
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $45.48
Upside: +12.14%
CVRx, Inc.
Nov 6, 2025
Maintains: Buy
Price Target: $9 → $11
Current: $9.26
Upside: +18.79%
Edwards Lifesciences
Nov 3, 2025
Maintains: Hold
Price Target: $81 → $84
Current: $83.98
Upside: +0.02%
iRhythm Technologies
Oct 31, 2025
Maintains: Buy
Price Target: $193 → $212
Current: $183.27
Upside: +15.68%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $106 → $99
Current: $64.85
Upside: +52.66%
TransMedics Group
Oct 30, 2025
Maintains: Buy
Price Target: $142 → $147
Current: $140.10
Upside: +4.93%
AtriCure
Oct 30, 2025
Maintains: Buy
Price Target: $53 → $64
Current: $36.27
Upside: +76.45%
Boston Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $132
Current: $98.57
Upside: +33.91%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $13.49
Upside: +33.43%
Sep 29, 2025
Maintains: Buy
Price Target: $24
Current: $19.93
Upside: +20.42%
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $1.34
Upside: +422.39%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $87.75
Upside: +2.56%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $93.10
Upside: +8.49%
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $6.43
Upside: +71.07%
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $18.00
Upside: +83.33%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.57
Upside: +98.15%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $285.71
Upside: -0.60%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $21.23
Upside: +17.76%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.89
Upside: +534.92%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $84.26
Upside: -16.92%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $26.37
Upside: +82.03%